“Risk and Resilience to Alzheimer’s Disease
in African Americans”

10:00am-10:20am: Adesola Ogunniyi (Ibadan University, Nigeria). “Comparing Alzheimer’s risk in African Americans and the Yoruba People of Nigeria”

10:20am-10:40am: Joyce Balls-Berry (Washington University St. Louis, MO). “Examining African Americans risk factors and susceptibility for Alzheimer’s disease.”

10:40am-11:00am: Carey Gleason (Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin, WI). “Incident dementia in non-Hispanic African Americans and whites with mild cognitive impairment.”

11:30am-11:50am: Goldie Byrd (Wake Forest, NC). “Genetic susceptibility of Alzheimer’s disease in African Americans.”

11:50am-12:10am: William Hu (Rutgers University-RBHS, NJ). “CSF and imaging biomarkers of Alzheimer’s disease in African Americans.”

1:30pm-1:40pm: Thomas Obisesan (Howard University, Washington, D.C.). “Alzheimer’s dementia in African Americans: Role of cardiovascular disease risk and opportunities for prevention.”

1:40pm-2:10pm: Robert Newton (Pennington Biomedical Research Center, LA). “The effect of a physical activity promotion program on cognitive function in older African American adults.”

2:10pm-2:30pm: Mark Gluck (Rutgers University-Newark, NJ). “Interactions between physical fitness and genetics on behavioral and biological markers of Alzheimer’s risk in older African Americans.”

3:00pm-3:40pm: (Chair, Michelle Papka, The Cognitive and Research Center of New Jersey). Speakers from Eisai Inc., Eli Lilly & Company, Genentech.

3:40pm-4:00pm: Carl Hill (Alzheimer’s Association). “Diversity and health disparities in Alzheimer’s research”

4:00pm-4:20pm: Damali Martin (National Institute on Aging, NIH). “Moving towards precision public health and precision medicine for minority health and health disparities research.”